ZX61 Stock Overview
Provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for ZX61 from our risk checks.
DSM-Firmenich AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €10.30 |
| 52 Week High | €10.80 |
| 52 Week Low | €8.60 |
| Beta | 0 |
| 11 Month Change | -1.90% |
| 3 Month Change | 11.35% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 8.42% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZX61 | DE Chemicals | DE Market | |
|---|---|---|---|
| 7D | -1.0% | 1.0% | 1.1% |
| 1Y | n/a | 8.3% | 10.7% |
Return vs Industry: Insufficient data to determine how ZX61 performed against the German Chemicals industry.
Return vs Market: Insufficient data to determine how ZX61 performed against the German Market.
Price Volatility
| ZX61 volatility | |
|---|---|
| ZX61 Average Weekly Movement | 3.7% |
| Chemicals Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: ZX61 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ZX61's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1902 | 27,926 | Dimitri de Vreeze | www.dsm-firmenich.com |
DSM-Firmenich AG provides solutions for nutrition, health, and beauty businesses in the Switzerland, Netherlands, rest of Europe, the Middle East and Africa, North America, Latin America, China, and rest of Asia. It operates through Perfumery & Beauty; Taste, Texture & Health; Health, Nutrition & Care; and Animal Nutrition & Health segments. The Perfumery & Beauty creates scents using natural, synthetic, and biotech ingredients.
DSM-Firmenich AG Fundamentals Summary
| ZX61 fundamental statistics | |
|---|---|
| Market cap | €31.24b |
| Earnings (TTM) | -€190.00m |
| Revenue (TTM) | €12.46b |
2.5x
P/S Ratio-164.4x
P/E RatioIs ZX61 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZX61 income statement (TTM) | |
|---|---|
| Revenue | €12.46b |
| Cost of Revenue | €9.07b |
| Gross Profit | €3.39b |
| Other Expenses | €3.58b |
| Earnings | -€190.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Feb 13, 2025
| Earnings per share (EPS) | -0.72 |
| Gross Margin | 27.19% |
| Net Profit Margin | -1.53% |
| Debt/Equity Ratio | 20.6% |
How did ZX61 perform over the long term?
See historical performance and comparison